Medical Condition News

RSS

Study assesses impact of ethnicity on second-line treatment of non-small cell lung cancer

Racial and ethnic minorities are more likely to develop cancer and die from it than the general U.S. population. However, as the next generation of cancer medicines are being evaluated, only 17 percent of clinical trial participants are, in fact, minorities.

21 Sep 2011

Saladax, Bristol-Myers Squibb expand Alzheimer's diagnostic assays agreement

Bristol-Myers Squibb Company and Saladax Biomedical, Inc., announced today they have expanded their multi-year agreement covering the development and commercialization of diagnostic assays for the early detection of Alzheimer's disease to include Ortho-Clinical Diagnostics, Inc.

21 Sep 2011

AACR releases landmark Cancer Progress Report 2011

The American Association for Cancer Research (AACR), today will release its AACR Cancer Progress Report 2011, in which its calls on Congress to increase funding for the National Institutes of Health (NIH) and the National Cancer Institute.

21 Sep 2011

Long-term immunosuppressants improve survival for lupus patients with ESKD

Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease—a finding that could reverse long-standing clinical practice.

21 Sep 2011

Study examines link between gestational age at birth and mortality in young adulthood

In a study that included more than 600,000 individuals born in Sweden between 1973-1979, those born preterm had a higher risk of death during early childhood and young adulthood than persons born at term, according to a study in the September 21 issue of JAMA.

21 Sep 2011

HRPR before PCI procedures linked to increased risk of ischemic event in ACS patients

Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine appropriate clopidogrel dosing and who had high residual platelet reactivity were at an increased risk of an ischemic event at short- and long-term follow-up of up to 2 years, according to a study in the September 21 issue of JAMA.

21 Sep 2011

Isolating 'bad' cells in rodent experiments may hold key to improving treatment for heart attacks

A UCSF study holds clues to why an emerging clinical trials option for heart attack patients has not been as successful as anticipated. Treatment of human hearts with bone marrow cells has led to limited to no success in improving their heart function even though a similar method has been much more effective in rodents.

21 Sep 2011

GI Dynamics introduces EndoBarrier Gastrointestinal Liner in Austria

GI Dynamics, Inc. today announced the launch of the EndoBarrier Gastrointestinal Liner in Austria, the establishment of the first two Centers of Excellence and the treatment of patients at each new Center.

21 Sep 2011

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that in a rodent contusion model of SCI the Company's proprietary biopolymer scaffold showed positive preliminary data that indicate a therapeutic effect.

21 Sep 2011

NUI Galway researchers develop super-sized model of heart valve

Researchers at NUI Galway have developed a super-sized model of a heart valve which may lead to a new generation of cardiovsacular devices.

21 Sep 2011

Free public lecture to reveal new insights into brain cells linked with stroke, cerebral palsy

A free public lecture at the University of Leicester is to discuss how the white matter of the brain could be the key to understanding and treating brain disorders - not grey matter as previously thought.

21 Sep 2011

Gothenburg researcher advises patients with acute low back pain to stay active

Move if you have back pain, this is the advice of a researcher at the Sahlgrenska Academy, University of Gothenburg. Patients with acute low back pain who were advised to stay active despite the pain fared better than those who were told to adjust their activity in line with their pain.

21 Sep 2011

Clinical trial to evaluate TAU's stem cell technology for ALS

The ability to produce neuroprotectors, proteins that protect the human brain against neurodegenerative disorders such as Parkinson's and ALS, is the holy grail of brain research. A technology developed at Tel Aviv University does just that, and it's now out of the lab and in hospitals to begin clinical trials with patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

21 Sep 2011

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

Boehringer Ingelheim today announced enrolment has commenced in its TOviTO Phase III clinical trial program. It will investigate tiotropium plus olodaterol in a once-daily fixed-dose combination for the treatment of chronic obstructive pulmonary disease.

21 Sep 2011

Foreign Affairs examines history of negotiations on NCD political declaration

Foreign Affairs on Tuesday published an analysis examining the history of negotiations behind the political declaration approved on Monday by leaders attending the U.N. High-level Meeting on Non-Communicable Diseases.

21 Sep 2011

Ono, Bristol-Myers Squibb partner to develop BMS-936558/ONO-4538 and ORENCIA

Bristol-Myers Squibb Company and Ono Pharmaceutical Co., Ltd., today announced an agreement to expand Bristol-Myers Squibb's territorial rights to develop and commercialize the anti-PD-1 antibody known as BMS-936558/ONO-4538, and to create a strategic alliance for the co-development and co-commercialization of ORENCIA in Japan.

21 Sep 2011

UNC's new nanoparticle shows potential for cancer chemotherapy

A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer.

21 Sep 2011

Children of parents with drink problem may consume more alcohol after stressful situations

If either of your parents has a drink problem, there is a greater risk that you will consume more alcohol after stressful situations, reveals current research from the Sahlgrenska Academy, at the University of Gothenburg, Sweden.

21 Sep 2011

World leaders unanimously approve NCD political declaration

World leaders attending the first-ever U.N. High-level Meeting on Non-communicable Diseases (NCDs) kicked off the summit on Monday by "unanimously approving a 'political declaration' meant to stem a rising tide of NCDs, now the world's leading killer," CNN reports.

21 Sep 2011

Global health experts discuss curbing rise of NCDs at Washington Post live event

The Washington Post reports on an event hosted last week by Washington Post Live, the division of the newspaper that organizes forums and debates, which brought together a number of attendees of the U.N. summit on non-communicable diseases (NCDs) wrapping up today in New York, as well as other key thinkers on global health, to discuss curbing the rise of NCDs.

21 Sep 2011

Medical Condition News

Study assesses impact of ethnicity on second-line treatment of non-small cell lung cancer

Saladax, Bristol-Myers Squibb expand Alzheimer's diagnostic assays agreement

AACR releases landmark Cancer Progress Report 2011

Long-term immunosuppressants improve survival for lupus patients with ESKD

Study examines link between gestational age at birth and mortality in young adulthood

HRPR before PCI procedures linked to increased risk of ischemic event in ACS patients

Isolating 'bad' cells in rodent experiments may hold key to improving treatment for heart attacks

GI Dynamics introduces EndoBarrier Gastrointestinal Liner in Austria

Positive data from InVivo's biomaterial scaffold implant preclinical study on acute SCI

NUI Galway researchers develop super-sized model of heart valve

Free public lecture to reveal new insights into brain cells linked with stroke, cerebral palsy

Gothenburg researcher advises patients with acute low back pain to stay active

Clinical trial to evaluate TAU's stem cell technology for ALS

Enrollment commences in Boehringer Ingelheim's TOviTO Phase III combination trial for COPD

Foreign Affairs examines history of negotiations on NCD political declaration

Ono, Bristol-Myers Squibb partner to develop BMS-936558/ONO-4538 and ORENCIA

UNC's new nanoparticle shows potential for cancer chemotherapy

Children of parents with drink problem may consume more alcohol after stressful situations

World leaders unanimously approve NCD political declaration

Global health experts discuss curbing rise of NCDs at Washington Post live event

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News